Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · February 18, 2023

Impact of Ferric Carboxymaltose for Iron Deficiency at Discharge After Heart Failure Hospitalisation

European Journal of Heart Failure


Additional Info

European Journal of Heart Failure
Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalisation: A European multinational economic evaluation
Eur. J. Heart Fail 2023 Jan 31;[EPub Ahead of Print], P McEwan, C Harrison, R Binnie, RD Lewis, A Cohen-Solal, LH Lund, M Ohlsson, S von Haehling, J Comin-Colet, DA Pascual-Figal, S Wächter, F Dorigotti, AR de Arellano, P Ponikowski, EA Jankowska

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading